Cargando...
Calcineurin inhibitors revisited: A new paradigm for COVID-19?
The Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) can cause mild, moderate or severe disease (COVID-19). In severe disease, there is hyperinflammation causing severe symptoms. Severe COVID-19 is an immunological phenomenon, rather than a direct viral damage disease. Therapies for COVI...
Guardado en:
| Publicado en: | Braz J Infect Dis |
|---|---|
| Autores principales: | , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Elsevier
2020
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7320855/ https://ncbi.nlm.nih.gov/pubmed/32603679 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bjid.2020.06.005 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|